Fred Robertson, MBA, M.D.,
Morgridge Institute > Morgridge Institute taps biomedical innovator as chairman
The trustees of the Morgridge Institute for Research have named Fred Robertson as chairman, replacing Ernie Micek, whose term as chair has ended and who will remain on the board.
Robertson served as CEO of two highly successful Wisconsin biomedical companies, TomoTherapy and GE Marquette Medical Systems.
He has been a member of the Morgridge Institute's Board of Trustees since 2011 and also serves on the board of the University of Wisconsin Foundation.
He is a faculty member with the Department of Anesthesiology at UW-Madison's School of Medicine and Public Health and earned his medical degree from the school.
Robertson also holds an MBA from San Diego State University.
brings a deep understanding of biomedical science to the role of chairman and he recognizes the challenges of translating basic research to the point where it can be applied to therapies and cures," Micek says.
In announcing the appointment of Robertson as chair, Brad Schwartz, CEO of the Morgridge Institute, also recognized the great service of Micek, a former CEO of Cargill.
Schwartz says the institute will continue to advance with Robertson
"It is a pleasure working with Fred as a member of our board of trustees and I know he has much to offer as chairman," Schwartz says.
looks forward to the role and welcomes the opportunity to further support the Morgridge Institute
scientists engaged in regenerative biology, virology, medical devices, core computational technology, bioethics and education outreach.
"The Morgridge Institute
leverages the collective research and educational strengths of the university to advance basic science and address critical human health challenges," says Robertson